Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia

[1]  E. Fibach,et al.  Pathophysiology and treatment of patients with beta-thalassemia – an update , 2017, F1000Research.

[2]  Y. Ismail,et al.  Peroxidative stress and antioxidant enzymes in children with &bgr;-thalassemia major , 2016 .

[3]  S. Srichairatanakool,et al.  Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State , 2015, Oxidative medicine and cellular longevity.

[4]  B. Djerdjouri,et al.  Oxidative Status and Plasma Lipid Profile in β-Thalassemia Patients , 2015, Hemoglobin.

[5]  A. Koc,et al.  N-Acetylcysteine Supplementation Reduces Oxidative Stress and DNA Damage in Children with β-Thalassemia , 2014, Hemoglobin.

[6]  A. Patne,et al.  Alterations in antioxidant enzyme status with lipid peroxidation in β thalassemia major patients , 2012 .

[7]  N. Rezaei,et al.  Total Antioxidant Status in Patients with Major β-Thalassemia , 2011, Iranian journal of pediatrics.

[8]  E. Fibach,et al.  The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia , 2010, Annals of the New York Academy of Sciences.

[9]  C. Hershko.  Pathogenesis and management of iron toxicity in thalassemia , 2010, Annals of the New York Academy of Sciences.

[10]  Enas A. Hamed,et al.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study , 2010, Italian journal of pediatrics.

[11]  P. Millea.  N-acetylcysteine: multiple clinical applications. , 2009, American family physician.

[12]  P. Betta,et al.  Oxidative stress and total antioxidant capacity in human plasma , 2009, Redox report : communications in free radical research.

[13]  A. Vercesi,et al.  Vitamin E Supplementation Reduces Oxidative Stress in Beta Thalassaemia Intermedia , 2009, Acta Haematologica.

[14]  A. Suryakar,et al.  Oxidative stress and disturbance in antioxidant balance in beta thalassemia major , 2008, Indian Journal of Clinical Biochemistry.

[15]  Richard J. Johnson,et al.  Uric Acid: The Oxidant-Antioxidant Paradox , 2008, Nucleosides, nucleotides & nucleic acids.

[16]  D. Atlas,et al.  N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells. , 2008, Biochimica et biophysica acta.

[17]  P. Le,et al.  Oxidative stress in patients with beta-thalassemia major. , 2007 .

[18]  V. Savov,et al.  Oxidative stress in patients with beta-thalassemia major. , 2007, Prilozi.

[19]  R. Naithani,et al.  Peroxidative stress and antioxidant enzymes in children with β‐thalassemia major , 2006 .

[20]  S. Rivella,et al.  Role of Iron in Inducing Oxidative Stress in Thalassemia: Can It Be Prevented by Inhibition of Absorption and by Antioxidants? , 2005, Annals of the New York Academy of Sciences.

[21]  N. Ganguly,et al.  Antioxidant status in children with homozygous thalassemia. , 2005, Indian pediatrics.

[22]  T. Dissayabutra,et al.  The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[23]  E. Fibach,et al.  Chronic oxidative stress reduces the respiratory burst response of neutrophils from beta‐thalassaemia patients , 2005, British journal of haematology.

[24]  G. Öztürk.  Oxidant and antioxidant status in beta thalassemia major patients , 2005 .

[25]  E. Fibach,et al.  Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[26]  S. Umemura,et al.  Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumour , 2004, The Journal of pharmacy and pharmacology.

[27]  O. Erel.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. , 2003, Clinical biochemistry.

[28]  A. Datta,et al.  Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. , 2004, Polish journal of pharmacology.

[29]  S. Laradi,et al.  Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[30]  B. Pace,et al.  Effects of N‐acetylcysteine on dense cell formation in sickle cell disease , 2003, American journal of hematology.

[31]  E. Fibach,et al.  Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells , 2003, European journal of haematology.

[32]  H. Freisleben,et al.  Iron status and oxidative stress in β‐thalassemia patients in Jakarta , 2003 .

[33]  M. Kampa,et al.  A new automated method for the determination of the Total Antioxidant Capacity (TAC) of human plasma, based on the crocin bleaching assay , 2002, BMC clinical pathology.

[34]  G. Rao,et al.  Comparison of the sensitivity of a 24 h-shell vial assay, and conventional tube culture, in the isolation of Herpes simplex virus – 1 from corneal scrapings , 2002, BMC clinical pathology.

[35]  M. Bhattacharyya,et al.  Antioxidant defense status of red blood cells of patients with β-thalassemia and Eβ-thalassemia , 2001 .

[36]  L. Tesoriere,et al.  Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in β-thalassemia intermedia patients , 2001, Free radical research.

[37]  A. Shah,et al.  The efficacy of reducing agents or antioxidants in blocking the formation of dense cells and irreversibly sickled cells in vitro. , 1998, Blood.

[38]  L. Tesoriere,et al.  Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. , 1996, Blood.

[39]  B. Rumack,et al.  Clinical safety of high oral doses of acetylcysteine. , 1983, Seminars in oncology.